BioSpace News Archive

CRG announced the appointment of Todd Holmes as Principal in the firm’s Boulder office.

Protagonist Therapeutics, Inc. announced that preclinical research findings on the Company’s selective dual mu/delta opioid receptor agonists have been accepted for oral presentation on Saturday, June 2, 2018 at the Digestive Diseases Week® (DDW) conference.

C4 Therapeutics (C4T) today announced that Andrew Phillips, Ph.D. has been appointed as President and Chief Executive Officer. Dr. Phillips has been leading C4T’s scientific efforts as Chief Scientific Officer since January 2016 and assumed corporate leadership responsibilities with his added appointment as President in September 2016

Syros Pharmaceuticals announced that it will host a live conference call and webcast at 8:30 a.m. ET on Thursday, May 10, 2018.

Catabasis Pharmaceuticals, Inc. will report first quarter 2018 financial results before the NASDAQ Global Market open on Thursday, May 10, 2018.

Virta Health announced new commercial partnerships with Tippecanoe County Government, Indiana and the City of Lafayette, Indiana.

Medizone International, Inc. announced the implementation and expansion of the Product Evaluation Agreement (the “Agreement”) with Innovasource, LLC.

U.S. Stem Cell, Inc. announced its Chief Science Officer, Dr. Kristin Comella, appeared live today as a featured guest for the Biohacker Summit blog

The Woodhull Study on Nurses and the Media, which first launched in 1997, will be presented at 9 a.m. ET May 8 at the National Press Club in Washington, D.C.

A report by Arcview Market Research indicates that consumer spending on legal cannabis in North America is outpacing previous estimates.